Tuesday, August, 20, 2019 03:11:45

Category: Health

Glenmark and Grandpharma ink pact to commercialize Ryaltris in China

The terms of the agreement state that Glenmark will be accountable for developing and supplying Ryaltris across China. Globally renowned pharmaceutical major Glenmark Pharmaceuticals has reportedly announced that its Swiss subsidiary has signed an exclusive licensing pact with Grandpharma (China) Co. Credible sources claim that …

Crescita, Tetra NHP partner to enhance dermatology product portfolio

The collaboration will effectively help optimize the delivery of Beta-C and several other active ingredients into patient’s skin and local tissues. Canada’s dermatology firm, Crescita Therapeutics Inc. and leading cannabinoid-derived drug provider, Tetra Bio-Pharma’s subsidiary, Tetra Natural Health (NHP) have recently announced an arrangement to …

HOOKIPA attains HIV collaboration and license agreement with Gilead

The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …